Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1530 studies found for:    "Acute lymphoblastic leukemia"
Show Display Options
RSS Create an RSS feed from your search for:
"Acute lymphoblastic leukemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed LAL-AR-N-2005:Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Prednisolone;   Drug: Daunorubicin;   Drug: Vincristine;   Drug: L-Asparaginase;   Drug: Cyclophosphamide;   Drug: Methotrexate;   Drug: Cytosine Arabinoside
2 Completed Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: vincristine;   Drug: dexamethasone
3 Not yet recruiting D-ALBA Frontline Sequential Dasatinib and Blinatumomab in Adult Philadelphia Positive Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Dasatinib;   Drug: Blinatumomab
4 Completed Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: asparaginase;   Drug: recombinant asparaginase
5 Completed Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention:
6 Unknown  Safety and Efficacy of Radio-immunotherapy (RIT) for Patients With Relapse or Refractory Acute Lymphoblastic Leukaemia (ALL) B CD22+
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: Epratuzumab and 90Y-Epratuzumab
7 Unknown  Genomic Changes in Childhood Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention:
8 Active, not recruiting Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008
Condition: Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: PEG-L-asparaginase ind;   Drug: PEG-L-asparaginase cons;   Drug: E.coli L-asparaginase;   Drug: High-dose Methotrexate;   Drug: Low-dose Methotrexate;   Drug: Triple intrathecal therapy;   Radiation: Cranial irradiation;   Drug: Daunorubicin
9 Active, not recruiting Treatment of High Risk Adult Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Vincristine;   Drug: Daunorubicin;   Drug: Prednisone;   Drug: Mitoxantrone;   Drug: Cytosine Arabinoside;   Drug: Dexamethasone;   Drug: Methotrexate (MTX);   Drug: Cytarabine;   Drug: ASP;   Drug: Mercaptopurine;   Drug: Teniposide;   Drug: Hydrocortisone
10 Completed Allogeneic Stem Cell Transplantation (SCT) With Treosulfan, VP-16 and Cyclophosphamid for Patients With Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Intervention: Procedure: Hematopoietic stem cell transplantation
11 Unknown  Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention:
12 Completed Treatment of Acute Lymphoblastic Leukemia in Children
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: prednisone;   Drug: dexamethasone;   Drug: doxorubicin;   Drug: E. coli asparaginase;   Drug: vincristine;   Drug: methotrexate;   Drug: Leucovorin;   Drug: Asparaginase;   Drug: cytarabine;   Drug: Methotrexate/Hydrocortisone
13 Completed LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Vincristine;   Drug: Daunorubicin;   Drug: Prednisone;   Drug: L-Asparaginase;   Drug: Mitoxantrone;   Drug: Cytosine Arabinoside;   Drug: Hydrocortisone;   Drug: Mercaptopurine;   Drug: Cyclophosphamide;   Drug: Dexamethasone
14 Active, not recruiting Haplo-identical HSCT Versus Chemotherapy for Adult Acute Lymphoblastic Leukemia Patients
Condition: Acute Lymphoblastic Leukemia
Interventions: Procedure: Haplo-identical HSCT;   Drug: Chemotherapy
15 Completed Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007
Condition: Acute Lymphoblastic Leukemia
Intervention:
16 Recruiting Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Condition: Acute Lymphoblastic Leukaemia
Interventions: Drug: VP16;   Radiation: TBI;   Drug: Thiotepa;   Drug: Treosulfan;   Drug: Fludarabine;   Drug: Busulfan
17 Completed
Has Results
Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: Cyclophosphamide (CTX);   Drug: Vincristine;   Drug: Doxorubicin;   Drug: Decadron;   Drug: G-CSF;   Drug: Methotrexate (MTX);   Drug: Ara-C;   Drug: Pegaspargase
18 Completed Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Intervention: Drug: GRASPA
19 Completed Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: imatinib;   Drug: cyclophosphamide;   Drug: daunorubicin;   Drug: vincristine;   Drug: prednisolone;   Drug: methotrexate;   Drug: cytarabine;   Drug: dexamethasone
20 Active, not recruiting A Study in Adults With Untreated Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: prednisone;   Drug: doxorubicin;   Drug: vincristine;   Drug: methotrexate;   Drug: asparaginase;   Drug: dexamethasone;   Radiation: cranial radiation;   Drug: leucovorin;   Drug: cytarabine;   Drug: hydrocortisone;   Drug: 6-mercaptopurine (6-MP);   Drug: e. coli L-asparaginase

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.